HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Concept Labs Hair Growth Inhibition Claims Unsubstantiated, NAD

This article was originally published in The Rose Sheet

Executive Summary

Ads claiming hair growth inhibition for Concept Laboratories Roll-On Hair Remover are unsubstantiated because of insufficient product testing, the National Advertising Division of the Council of Better Business Bureaus states in its March NAD Case Reports.

You may also be interested in...



ProCede Implied Hair Growth Claims Should Be Modified – NAD

Youth Enhancement Systems should modify implied claims that ProCede hair thickener causes "significant and dramatic hair growth," the National Advertising Division of the Council of Better Business Bureaus concludes in a recent Case Reports

ProCede Implied Hair Growth Claims Should Be Modified – NAD

Youth Enhancement Systems should modify implied claims that ProCede hair thickener causes "significant and dramatic hair growth," the National Advertising Division of the Council of Better Business Bureaus concludes in a recent Case Reports

Thane Hair Removal Claims Overstated, Need Modification - NAD

Performance claims for Thane International's Alexandria Body Sugaring hair removal system should be modified "to avoid overstating the inhibition of hair regrowth that consumers can expect with the use of the product," the National Advertising Division of the Council of Better Business Bureaus says in its January NAD Case Reports.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel